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ABSTRACT
Oxidative stress may be the major cause of induction of Shiga toxin-converting (Stx) prophages from chro-
mosomes of Shiga toxin-producing Escherichia coli (STEC) in human intestine. Thus, we aimed to test a ser-
ies of novel antioxidant compounds for their activities against prophage induction, thus, preventing
pathogenicity of STEC. Forty-six compounds (derivatives of carbazole, indazole, triazole, quinolone, ninhy-
drine, and indenoindole) were tested. Fifteen of them gave promising results and were further character-
ized. Eleven compounds had acceptable profiles in cytotoxicity tests with human HEK-293 and HDFa cell
lines. Three of them (selected for molecular studies) prevent the prophage induction at the level of expres-
sion of specific phage genes. In bacterial cells treated with hydrogen peroxide, expression of genes
involved in the oxidative stress response was significantly less efficient in the presence of the tested com-
pounds. Therefore, they apparently reduce the oxidative stress, which prevents induction of Stx prophage
in E. coli.
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Introduction
The significance of Shiga toxin-producing Escherichia coli (STEC) as
a public health problem was recognized in 1982 in USA, during an
investigation of the outbreak of hemorrhagic colitis associated
with consumption of contaminated hamburgers1. Since then, STEC
strains have been implicated in many outbreaks of diarrhea world-
wide. Quite recently (2011), the Shiga toxin-producing E. coli sero-
type O104:H4 was responsible for a serious epidemic outbreak in
Germany2,3. STEC pathogens can cause serious food poisoning
with bloody diarrhea in humans4. Their main virulence factors are
Shiga toxins, encoded by stx genes located in genomes of bacter-
iophages, which occur in bacteria as prophages5. These bacterio-
phages are called Shiga toxin-converting or shortly Stx phages
and belong to the lambdoid family of phages6. All phages within
this group indicate high similarities in the lifecycle and genomic
organization to bacteriophage k, the most reviewed member of
this family7. In the prophage state, most of phage genes, including
stx genes, are not transcribed due to inhibition caused by the
phage cI repressor. Consequently, Shiga toxins are not produced
under such conditions. Expression of stx as well as other phage
genes occurs effectively only after prophage induction. In most
cases, this process requires activation of the RecA-dependent bac-
terial S.O.S. response, which is provoked by factors causing
appearance of single-stranded DNA fragments. Activated RecA
protein stimulates cleavage of both the SOS regulon repressor, the
LexA protein, and the cI phage repressor. Prophage induction and
subsequent phage lytic development lead to production of pro-
geny phage particles and Shiga toxins, and then to their release
from the lysed cell8.
Induction of lambdoid prophages is easy and can be provoked
by different inducers like treatment with targeted DNA antibiotics
(e.g. mitomycin C), UV-treatment7, EDTA9, 60Co irradiation10, high
hydrostatic pressure11, and many others. Such conditions do not
naturally occur in the human gut, the place where the STEC infec-
tion initiates. Therefore, the oxidative stress conditions, which
appear in human intestine as a response to STEC infection, has
attracted attention of researchers. Indeed, it has been shown that
hydrogen peroxide (which is excreted by neutrophils during infec-
tion) increases efficiency of Stx prophage induction and stimulates
production of Shiga toxins12–14. In bacteria, H2O2 acts as a DNA-
damaging agent that interacts with free cellular iron and form
hydroxyl radicals OH in Fenton reaction. DNA subjected to attack
by OH generates a wide range of base and sugar modifications
and strand breaks, which in turn activate the RecA protein and
SOS response15. According to hypothesis proposed by two differ-
ent research groups16,17, STEC strains may obtain advantage due
to H2O2-mediated production of Shiga toxins. As demonstrated,
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these toxins are produced in a small fraction of STEC cells (usually
less than 1%) which are sacrificed for the good of the whole bac-
terial population. Released toxins kill H2O2-producing protozoan
predator, so allowing the rest of bacteria to survive its attack. It is
suspected that STEC response to attack of neutrophils in human
intestine might be analogous16,17.
The OxyR and SoxR regulators mainly control E. coli defense
against oxidative stress. Interestingly, H2O2 activate genes of both
regulons: OxyR (about 30 genes) and SoxRS (about 17 genes)18. It
was demonstrated that nitric oxide and its derivatives (NOs) as
well as S-nitrosothiols (SNOs) may be involved in signaling in bac-
teria and may change properties of several bacterial proteins
including OxyR, SoxR, NorR and Fur in Escherichia coli19–22, as well
as ResDE in Bacillus subtilis23. As reported previously, certain SNOs
are able to provoke a nitrosative stress in E. coli bacteria, evi-
denced by lowering of intracellular thiol and the transcriptional
activation of OxyR by S-nitrosylation24. OxyR is a thiol-containing
transcriptional activator of antioxidant genes that are involved in
H2O2 detoxification. The activation of E. coli antioxidant enzymes
by OxyR in response to H2O2 has been widely described. The
genes controlled by OxyR include catalase/hydroperoxidase (katG),
glutathione reductase (gorA), and alkyl hydroperoxide reductase
(ahpCF). Their expression is essential to ensure resistance to
H2O2
24–26. As demonstrated previously, S-nitrosylation, S-hydroxyl-
ation, and S-glutathionylation of wild-type OxyR activate this pro-
tein and appear to serve as the functional switches in the
activation of OxyR-regulated genes24,27. On the other hand, nitric
oxide (NO) donors are able to activate SoxRS regulon and induce
the expression of enzymes involved in the oxidative stress
response of E. coli bacteria, such as the superoxide dismu-
tase (sodA)28,29.
It was previously proposed that OxyR may be responsible for
the lambdoid prophage maintenance under conditions of the oxi-
dative stress8. Other studies indicated that under such conditions,
activated OxyR is able to compete effectively with the cI protein
(the main repressor of phage lytic development) for the binding
to the oR3 operator of the pM-pR promoter region
30. These results
allowed to suggest that OxyR might enhance repression of pR (the
major promoter for expression of genes of phage lytic lifecycle)
and enhance activation, and at the same time also downregulate
repression, of the transcription of the cI gene from the pM pro-
moter. This would lead to higher (relative to normal growth condi-
tions) activity of pM, increased production of cI repressor and
lower efficiency of prophage induction under the oxidative stress.
In the light of the importance of the oxidative stress in induc-
tion of Stx prophages and Shiga toxin production (summarized
above), we analyzed in this study impact of the different antioxi-
dant compounds, on viability of STEC and development of the Stx
phage U24B. Since virulence of STEC depends on the prophage
induction, and in the light of the fact that most of antibiotics
should not be used for treatment of STEC-infected patients, devel-
opment of novel drugs that would impair survival of STEC (with-
out causing prophage induction) or prophage induction/
development or both would be highly desirable. Although devel-
opment of novel compounds which might be potentially used to
combat E. coli infections, exemplified by those based on furanyl-
derived sulfonamides, has been reported31, and sophisticated
techniques become available to either engineer E. coli surface32 or
to use nanoparticles as carriers of compounds33, the anti-bacterial
activity of these molecules were moderate31. Therefore, we have
tested a series of novel compounds that are derivatives of carba-
zole, indazole, triazole, quinolone, ninhydrin, and indenoindole.
Materials and methods
Chemistry
Chemical structures of all compounds tested in this report are pre-
sented in the supporting information (Supplementary Figures 1–4)
with the corresponding references. Seven indenoindole derivatives
are described in this paper (CM3159A, MF4, THN10, CM3072B,
CM3159B, MF5, MF1). Melting points were determined on an
Electrothermal 9200 capillary apparatus. The IR spectra were
recorded on a PerkinElmer Spectrum Two IR spectrometer. The 1H
and 13C NMR spectra were recorded on a Bruker DRX 400 spec-
trometer. Chemical shifts are expressed in ppm (d) downfield from
internal tetramethylsilane, and coupling constants J are reported
in hertz (Hz). The following abbreviations are used: s, singlet; bs,
broad singlet; d, doublet; t, triplet; dd, doubled doublet; q, quartet;
sept, septuplet; m, multiplet; Cquat, quaternary carbons. The mass
spectra were performed by direct ionization (EI or CI) on a
ThermoFinnigan MAT 95 XL apparatus. Chromatographic separa-
tions were performed on silica gel columns by column chromatog-
raphy (Kieselgel 300–400 mesh). All reactions were monitored by
TLC on GF254 plates that were visualized under a UV lamp
(254 nm). Evaporation of solvent was performed in vacuum with
rotating evaporator. The purity of the final compounds (greater
than 95%) was determined by uHPLC/MS on an Agilent 1290 sys-
tem using a Agilent 1290 Infinity ZORBAX Eclipse Plus C18 column
(2.1 50mm, 1.8lm particle size) with a gradient mobile phase of
H2O/CH3CN (90:10, v/v) with 0.1% of formic acid to H2O/CH3CN
(10:90, v/v) with 0.1% of formic acid at a flow rate of 0.5ml/min,
with UV monitoring at the wavelength of 254 nm. A run time of
10min was applied. LC/HRMS data of all new indenoindole deriva-
tives are presented in the supporting information.
General procedure for the synthesis of compound 3
A solution containing equimolar amounts of enaminone 2 and
ninhydrin 1 dissolved in MeOH was stirred at room temperature
for 19 h. Generally, a precipitate of compound 3 was formed. The
solvent was evaporated, and the product triturated, filtrated and
washed with EtOAc. A second quantity could be obtained from
the filtrate by purification by silica gel column chromatography
with CH2Cl2/acetone (96:4, v/v) as the eluent.
Mixture of regioisomers 4 b,9 b-Dihydroxy-5-isopropyl-1-methoxy-
4 b,5,6,7,8,9 b-hexahydroindeno[1,2-b]indole-9,10-dione (major, MAJ)
and 4 b,9 b-Dihydroxy-5-isopropyl-4-methoxy-4 b,5,6,7,8,9 b-hexahy-
droindeno[1,2-b]indole-9,10-dione (minor, min) CM3072A: beige
solid. Yield 77%. IR (t cm1): 3368, 1714, 1595, 1532, 1491 cm1.
1H NMR (300MHz, DMSO-d6) d: 7.73 (t, 1H, J¼ 8.1 Hz, H-2 MAJ),
7.54 (t, 1H, J¼ 7.9 Hz, H-3min), 7.44 (d, 1H, J¼ 7.5 Hz, H-4 MAJ),
7.38 (d, 1H, J¼ 7.5 Hz, H-3min), 7.26 (d, 1H, J¼ 7.3 Hz, H-2min),
7.12 (d, 1H, J¼ 8.3 Hz, H-4 MAJ), 6.66 (s, 1H, OH MAJ), 6.32 (s, 1H,
OH min), 5.73 (s, 1H, OH min), 5.54 (s, 1H, OH MAJ), 4.85 (sept, 1H,
J¼ 7.1 Hz, CH(CH3)2min), 4.54 (sept, 1H, J¼ 7.1 Hz, CH(CH3)2 MAJ),
3.95 (s, 3H, OCH3 min), 3.88 (s, 3H, OCH3 MAJ), 2.62–2.82 (m, 4H,
H-6 MAJþmin), 2.06–2.13 (m, 4H, H-8 MAJþmin), 1.79–1.91 (m,
4H, H-7 MAJþmin), 1.45 (d, 3H, J¼ 6.8 Hz, CH3 MAJ), 1.39 (d, 3H,
J¼ 7.2 Hz, CH3 min), 1.33 (d, 3H, J¼ 7.0 Hz, CH3 min), 1.25 (d, 3H,
J¼ 7.1 Hz, CH3 MAJ).
4 b,9 b-Dihydroxy-5-isopropyl-1,4-dimethoxy-4 b,5,6,7,8,9 b-hexahy-
droindeno[1,2-b]indole-9,10-dione CM3159A: beige solid. Yield 66%.
Mp 216 C. IR (t cm1): 3347, 1717, 1497, 1270, 999. 1H NMR
(400MHz, DMSO-d6) d: 7.30 (d, 1H, J¼ 8.9 Hz, H-3), 7.05 (d, 1H,
J¼ 8.9 Hz, H-2), 6.27 (s, 1H, OH), 5.65 (s, 1H, OH), 4.82 (sept, 1H,
J¼ 7.1 Hz, CH(CH3)2), 3.88 (s, 3H, OCH3), 3.80 (s, 3H, OCH3),
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2.70–2.79 (m, 1H, CH2), 2.40–2.50 (m, 1H, CH2), 2.06 (t, 2H,
J¼ 6.3 Hz, CH2), 1.75–1.84 (m, 2H, CH2), 1.36 (d, 3H, J¼ 7.1 Hz,
CH3), 1.31 (d, 3H, J¼ 7.1 Hz, CH3). 13C NMRþDEPT (100MHz,
DMSO-d6) d: 194.7 (C¼O), 188.7 (C¼O), 165.5 (Cquat), 150.6
(Cquat), 149.5 (Cquat), 136.1 (Cquat), 124.3 (Cquat), 118.4 (CH),
112.9 (CH), 106.2 (Cquat), 95.8 (Cquat), 82.9 (Cquat), 55.7 (2 OCH3),
45.1 (CH), 36.7 (CH2), 24.5 (CH2), 22.4 (CH3), 22.2 (CH3), 21.8 (CH2).
HRMS calcd for C20H24NO6 [MþH]þ 374.1598 found, 374.1599.
4 b,9 b-Dihydroxy-5-isopropyl-2,3-dimethoxy-4 b,5,6,7,8,9 b-hexahy-
droindeno[1,2-b]indole-9,10-dione MF4: white solid. Yield 87%. Mp
206 C. IR (t cm1): 3071, 1727, 1712, 1488, 1284, 1174, 954. 1H
NMR (400MHz, DMSO-d6) d: 7.39 (s, 1H, H-1), 7.09 (s, 1H, H-4), 6.60
(s, 1H, OH), 5.50 (s, 1H, OH), 4.64 (sept, 1H, J¼ 7.1 Hz, CH(CH3)2),
3.92 (s, 3H, OCH3), 3.83 (s, 3H, OCH3), 2.44–2.70 (m, 2H, CH2), 2.05
(t, 2H, J¼ 6.3 Hz, CH2), 1.72–1.85 (m, 2H, CH2), 1.43 (d, 3H,
J¼ 7.1 Hz, CH3), 1.24 (d, 3H, J¼ 7.1 Hz, CH3). 13C NMRþDEPT
(75MHz, DMSO-d6) d: 196.2 (C¼O), 188.8 (C¼O), 164.2 (Cquat),
155.5 (Cquat), 151.0 (Cquat), 142.9 (Cquat), 127.9 (Cquat), 105.7
(CH), 105.5 (Cquat), 103.6 (CH), 95.4 (Cquat), 82.8 (Cquat), 56.3
(OCH3), 55.7 (OCH3), 44.7 (CH), 36.7 (CH2), 24.3 (CH2), 22.6 (CH3),
22.1 (CH3), 22.0 (CH2). HRMS calcd for C20H24NO6 [MþH]þ
374.1598, found 374.1603.
4 b,9 b-Dihydroxy-5-isopropyl-1-nitro-4 b,5,6,7,8,9 b-hexahydroin-
deno[1,2-b]indole-9,10-dione AM10A: yellow solid. Yield 92%. Mp
227 C. IR (t cm1): 3553, 1746, 1589, 1536, 1491. 1H NMR
(500MHz, DMSO-d6) d: 8.28 (d, 1H, J¼ 7.6 Hz, H-4), 8.04 (d, 1H,
J¼ 7.6 Hz, H-2), 7.99 (t, 1H, J¼ 7.6 Hz, H-3), 7.04 (s, 1H, OH), 5.87 (s,
1H, OH), 4.61 (sept, 1H, J¼ 7.2 Hz, CH(CH3)2), 2.41–2.77 (m, 2H,
CH2), 2.10 (t, 2H, J¼ 6.0 Hz, CH2), 1.84 (m, 2H, CH2), 1.45 (d, 3H,
J¼ 6.9 Hz, CH3), 1.27 (d, 3H, J¼ 6.9 Hz, CH3). 13C NMRþDEPT
(125MHz, DMSO-d6) d: 192.8 (C¼O), 188.7 (C¼O), 164.9 (Cquat),
148.8 (Cquat), 145.1 (Cquat), 136.1 (CH), 128.9 (CH), 126.5 (Cquat),
124.8 (CH), 104.5 (Cquat), 94.6 (Cquat), 83.3 (Cquat), 44.9
(CH(CH3)2), 36.7 (CH2), 24.2 (CH2), 22.5 (CH3), 22.4 (CH3), 21.9 (CH2).
HRMS calcd for C18H19N2O6 [MþH]þ, 359.1238 found: 359.1240.
General procedure for the synthesis of compound 4
A solution containing 5.92mmol of 3 and 11.5mmol (2 equiv) of
TETA dissolved in 18ml of DMF and 3.5ml of AcOH was stirred at
room temperature for 22 h. The solution was then poured into
50ml of ice and water and stirred for 30min. The resulting precipi-
tate was filtered, washed with water and dried to give a first quan-
tity of 4. EtOAc was added to the filtrate, and the organic product
extracted. The organic phase was washed with water, dried over
anhydrous Na2SO4 and evaporated in vacuum to give a second
quantity of 4 which was purified by silica gel column chromatog-
raphy with CH2Cl2/acetone (95:5, v/v) as the eluent.
5-Isopropyl-1-methoxy-5,6,7,8-tetrahydroindeno[1,2-b]indole-9,10-
dione THN10: brown solid. Yield 50%. Mp 186 C. IR (t cm1):
1694, 1661, 1590, 1261, 1023, 803. 1H NMR (400MHz, DMSO-d6) d:
7.38 (dd, 1H, J1¼ 8.6 Hz, J2¼ 7.5 Hz, H-3), 7.04 (d, 1H, J¼ 7.3 Hz, H-
4), 6.98 (d, 1H, J¼ 8.8 Hz, H-2), 4.77 (sept, 1H, J¼ 6.9 Hz, CH(CH3)2),
3.86 (s, 3H, OCH3), 2.93 (m, 2H, CH2), 2.37 (m, 2H, CH2), 2.08 (m,
2H, CH2), 1.57 (d, 6H, J¼ 7.1 Hz, CH3). 13C NMRþDEPT (100MHz,
DMSO-d6) d: 191.2 (C¼O), 182.2 (C¼O), 156.8 (2 Cquat), 150.1 (2
Cquat), 136.8 (2 Cquat), 135.1 (CH), 121.2 (Cquat), 114.7 (CH), 112.8
(CH), 55.6 (OCH3), 49.5 (CH(CH3)2), 37.7 (CH2), 22.8 (2 CH2), 21.3 (2
CH3). HRMS calcd for C19H20NO3 [MþH]þ 310.1438,
found: 310.1438.
5-Isopropyl-4-methoxy-5,6,7,8-tetrahydroindeno[1,2-b]indole-9,10-
dione CM3072B: red solid. Yield 24%. Mp 224 C. IR (t cm1): 3436,
1704, 1660, 1600, 1488, 1270. 1H NMR (400MHz, DMSO-d6) d:
7.19–7.28 (m, 2H, H-1 and H-2), 7.02 (d, 1H, J¼ 8.8 Hz, H-3), 5.67
(m, 1H, CH(CH3)2), 2.94 (s, 3H, OCH3), 3.00 (m, 2H, CH2), 2.38 (t, 2H,
J¼ 6.3 Hz, CH2), 2.07 (t, 2H, J¼ 6.0 Hz, CH2), 1.56 (d, 6H, J¼ 7.0 Hz,
CH3).
13C NMRþDEPT (100MHz, DMSO-d6) d: 191.4 (C¼O), 183.1
(C¼O), 150.2 (Cquat), 149.8 (2 Cquat), 139.6 (2 Cquat), 130.6 (CH),
121.2 (2 Cquat), 119.2 (CH), 116.3 (CH), 56.3 (OCH3), 51.0
(CH(CH3)2), 37.7 (CH2), 24.5 (CH2), 23.4 (CH2), 21.6 (2 CH3). HRMS
calcd for C19H20NO3 [MþH]þ 310.1438, found: 310.1435.
1,4-Dimethoxy-5-isopropyl-5,6,7,8-tetrahydroindeno[1,2-b]indole-
9,10-dione CM3159B: orange-red solid. Yield 75%. Mp 247 C. IR (t
cm1): 1693, 1661, 1494, 1262. 1H NMR (400MHz, DMSO-d6) d:
7.19 (d, 1H, J¼ 9.3 Hz, H-3), 6.99 (d, 1H, J¼ 9.3 Hz, H-2), 5.71 (m,
1H, CH(CH3)2), 3.90 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 2.99 (m, 2H,
CH2), 2.36 (m, 2H, CH2), 2.06 (m, 2H, CH2), 1.54 (d, 6H, J¼ 7.1 Hz,
CH3).
13C NMRþDEPT (75MHz, DMSO-d6) d: 191.2 (C¼O), 181.7
(C¼O), 151.9 (2 Cquat), 149.9 (Cquat), 144.3 (2 Cquat), 122.8
(Cquat), 122.2 (Cquat), 121.5 (CH), 117.1 (CH), 56.0 (2 OCH3), 50.7
(CH(CH3)2), 37.7 (2 CH2), 23.4 (CH2), 21.6 (CH3). HRMS calcd for
C20H21NNaO4 [MþNa]þ 362.1363, found: 362.1364.
2,3-Dimethoxy-5-isopropyl-5,6,7,8-tetrahydroindeno[1,2-b]indole-
9,10-dione MF5: red solid. Yield 74%. Mp 245 C. IR (t cm1): 1696,
1659, 1268. 1H NMR (400MHz, DMSO-d6) d: 7.04 (s, 1H, H-1), 6.97
(s, 1H, H-4), 4.77 (sept, 1H, J¼ 6.9 Hz, CH(CH3)2), 3.93 (s, 3H, OCH3),
3.84 (s, 3H, OCH3), 2.94 (m, 2H, CH2), 2.38 (t, 2H, J¼ 6.0 Hz, CH2),
2.10 (t, 2H, J¼ 5.9 Hz, CH2), 1.61 (d, 6H, J¼ 6.5 Hz, CH3). 13C
NMRþDEPT (100MHz, DMSO-d6) d: 190.6 (C¼O), 182.6 (C¼O),
151.4 (Cquat), 150.6 (Cquat), 148.8 (Cquat), 148.1 (Cquat), 130.8
(Cquat), 128.6 (Cquat), 118.6 (Cquat), 116.9 (Cquat), 109.2 (CH),
106.0 (CH), 56.3 (OCH3), 55.9 (OCH3), 48.9 (CH(CH3)2), 37.3 (CH2),
22.6 (CH2), 22.5 (CH2), 21.2 (2 CH3). HRMS calcd for C20H21NNaO4
[MþNa]þ 362.1363, found: 362.1366.
5-Isopropyl-1-nitro-5,6,7,8-tetrahydroindeno[1,2-b]indole-9,10-dione
AM12B: red solid. Yield 80%. Mp 244 C. IR (t cm1): 1707, 1666,
1605, 1536. 1H NMR (400MHz, DMSO-d6) d: 7.63 (d, 1H, J¼ 7.5 Hz,
H-2), 7.59 (t, 1H, J¼ 7.5 Hz, H-3), 7.49 (d, 1H, J¼ 7.0 Hz, H-4), 4.80
(sept, 1H, J¼ 7.0 Hz, CH(CH3)2), 2.95 (m, 2H, CH2), 2.37 (t, 2H,
J¼ 6.0 Hz, CH2), 2.06 (m, 2H, CH2), 1.56 (d, 6H, J¼ 7.0 Hz, CH3). 13C
NMRþDEPT (100MHz, DMSO-d6) d: 190.8 (C¼O), 177.8 (C¼O),
155.7 (2 Cquat), 149.7 (Cquat), 145.5 (Cquat), 136.0 (2 Cquat),
134.9 (CH), 127.4 (Cquat), 121.6 (CH), 121.0 (CH), 49.5 (CH(CH3)2),
37.3 (CH2), 22.8 (CH2), 22.5 (CH2), 21.2 (2 CH3). HRMS calcd for
C18H16N2NaO4 [MþNa]þ, 347.1002 found: 347.0989.
1-Amino-5-isopropyl-5,6,7,8-tetrahydroindeno[1,2-b]indole-9,10-
dione MF1: To a stirred solution of nitro derivative AM12B
(485mg, 1.50mmol) in 4.9ml of glacial acetic and 3.4ml of water
at 90 C was added iron (686mg, 12.2mol) in portions. The result-
ing suspension was stirred at the same temperature for 45min.
Then, the reaction mixture was cooled to room temperature and
basified with saturated NaHCO3 aqueous solution. The organic
phase was extracted with dichloromethane washed with brine,
dried with Na2SO4, filtered and evaporated to dryness. The residue
was purified by silica gel column chromatography with CH2Cl2/
acetone (1:1, v/v) as the eluent to afford 254mg of MF1: yellow
solid. Yield 58%. Mp 238 C. IR (t cm1): 3448, 3351, 1673, 1625,
1463. 1H NMR (400MHz, DMSO-d6) d: 7.07 (t, 1H, J¼ 7.7 Hz, H-3),
6.64 (d, 1H, J¼ 7.1 Hz, H-2), 6.57 (d, 1H, J¼ 8.6 Hz, H-4), 6.34 (bs,
2H, NH2), 4.72 (sept, 1H, J¼ 7.0 Hz, CH(CH3)2), 2.93 (t, 2H,
J¼ 6.0 Hz, CH2), 2.38 (t, 2H, J¼ 6.0 Hz, CH2), 2.07–2.13 (m, 2H, CH2),
1.57 (d, 6H, J¼ 6.8 Hz, CH3). 13C NMRþDEPT (100MHz, DMSO-d6)
d: 191.0 (C¼O), 186.4 (C¼O), 149.1 (Cquat), 148.3 (Cquat), 146.8
(Cquat), 134.8 (Cquat), 133.3 (CHþCquat), 118.8 (CH), 116.3
(Cquat), 114.0 (Cquat), 109.0 (CH), 48.7 (CH(CH3)2), 37.5 (CH2), 22.7
(2 CH2), 20.9 (2 CH3). HRMS calcd for C18H18N2NaO2 [MþNa]þ
317.1260, found: 317.1259.
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Prophage induction experiment
E. coli MG1655 strain34 lysogenic for phage U24B Dstx2::cat
35 was
cultured in LB medium at 37 C with one of the analyzed com-
pounds (Supplementary Figures S1–S4), in the presence or
absence of the prophage inductor: 0.2mg/ml; 0.5mg/ml mitomy-
cin C or 1mM H2O2. In control experiments, DMSO (a solvent
used for preparation of stock solutions) was added instead of
the tested compound. Each analyzed compound was added at
the beginning of the culture (time 0), at three different concen-
trations (50, 100 and 200 lM), and selected prophage inductor
was added after 3 h. Measurements of the bacterial cultures
optical density at 600 nm (A600) were performed at indicated
times (0, 3, 5, 7, and 9 h). Six hours after an induction (at the
ninth hour of the experiment), 50 ll samples were withdrawn,
mixed with 10ml of chloroform and centrifuged (4,500 rpm,
5min). Serial dilutions were prepared in TM buffer (10mM
Tris–HCl, 10mM MgSO4; pH 7.2). Phage titer (number of phages
per ml) was determined by spotting 2.5 ll of each dilution of the
phage lysate on a freshly prepared LB agar (1.5%) with 2.5lg/ml
chloramphenicol, to obtain visible plaques formed on bacterial
lawn (according to a procedure described previously36), with a
poured mixture of 1ml indicator E. coli MG1655 strain culture
and 2ml of 0.7% nutrient agar (prewarmed to 45 C), supple-
mented with MgSO4 and CaCl2 (to a final concentration of
10mM each). Plates were incubated at 37 C overnight. Each
experiment was repeated three times. The relative phage titer
(PFU/ml) representing ratios of phage titers in induced and non-
induced cultures was calculated and presented as percentage of
relative phage titer obtained in control experiments, with DMSO
added instead of the analyzed compound.
MTT cell viability assay: 3 103 HEK-293 (Human Embryonic
Kidney) or HDFa (Human Dermal Fibroblast, adult) cells were pas-
saged in each well of 96-well plate, and allowed to attached over-
night. Cells were then treated with DMSO (control cells) or 50, 100
or 200mM of tested compound at 37 C. After 48 h incubation,
25ml of MTT solution (4mg/ml) was added to each well. Following
3 h incubation at 37 C, formazan crystals, formed in living cells,
were dissolved in 100 ml of DMSO. Absorbance was measured at
570 and 620 nm (reference wavelength) in a Victor3 micro-
plate reader.
Bacterial RNA preparation: For the extraction of total RNA
from E. coli strain MG1655 lysogenic for U24B bacteriophage, the
procedure described in previous subsection was employed with
slight modification. Three selected compounds: CM092, CM032D,
and CM3186 were added to the bacterial culture at time 0 to a
final concentration 200 mM. The control experiment was treated
with DMSO solution, which allows estimation of impact of tested
compounds on prophage induction. After 3 hours of bacterial culti-
vation at 37 C, phage lytic development was provoked by add-
ition of 1mM H2O2. At indicated time after prophage induction,
1 109 bacterial cells were treated with 10mM NaN3 (Sigma-
Aldrich), harvested and frozen in a liquid nitrogen. The RNA sam-
ples were prepared using the High Pure RNA Isolation Kit (Roche
Table 1. Primers used in the real-time PCR assay.
Primer name Sequence (50!30)
pF_OxyR
pR_OxyR
GCAGGTAGCGGGATCACTTT
GCACGGCAGATAAACAACCC
pF_KatG
pR_KatG
GCTCTGCCTGTTCTGGAGAA
CACACCAGCCAGCACTATGA
pF_AhpC
pR_AhpC
GCTGGAGCGTCTTCTTCTTCT
TAGTGGTCAGCAACGTCACC
pF_CysD
pR_CysD
ATTTGCCCGTTGTAGTTGTGC
TACTCTTTCCGTGACCGCTTC
pF_SodA
pR_SodA
CTGCCAGAATTTGCCAACCTG
GTACGGTTTTCTTGTCTGCTGG
pF_SoxR
pR_SoxR
AAACAGCTTTCGTCCCAATGG
TACATCCGTCCAGTTCGTCAC
pF_SoxS
pR_SoxS
GCTGGGAGTGCGATCAAACT
GCAATGGACCTGGGTTATGTGT
pF_16SrRNA
pR_16SrRNA
CCTTACGACCAGGGCTACAC
TTATGAGGTCCGCTTGCTCT
pF_U24B_N
pR_ U24B_N
AGGCGTTTCGTGAGTACCTT
TTACACCGCCCTACTCTAAGC
pF_U24B_cI
pR_U24B_cI
TGCTGTCTCCTTTCACACGA
GCGATGGGTGGCTCAAAATT
pF_U24B_cII
pR_U24B_cII
TGATCGCGCAGAAACTGATTTAC
GACAGCCAATCATCTTTGCCA
pF_U24B_Q
pR_U24B_Q
GGGAGTGAGGCTTGAGATGG
TACAGAGGTTCTCCCTCCCG
Table 2. Differences in OD values resulting from comparison of bacterial growth
(E. coli strain MG1655 lysogenic for U24B) in control culture (DMSO) and cultures
carried out with the analyzed compounds. Each experiment was conducted dur-
ing 9 h, in the presence or absence of mitomycin C (MITC).
Effects on the lysogenic strain growtha
50 mM 100 mM 200 mM
No Compound –MITC þMITC –MITC þMITC –MITC þMITC
1 BZ23 –12 9 –12 5 –22 12
2 BZ26 7 52 –1 48 –2 >100
3 BZ102 –1 12 –22 2 –25 8
4 BZ105 –23 –16 –20 –29 30 –44
5 BZ106 –2 –11 –7 –68 –97 –96
6 BZ86 1 29 –2 24 –18 15
7 BZ70 0 41 –3 54 –7 40
8 BZ83 12 12 7 –2 –7 –18
9 BZ64 0 26 0 12 –18 11
10 BZ96 1 10 –1 15 –7 –2
11 BZ89 –2 8 2 –6 2 –36
12 IA011C 14 83 18 >100 16 >100
13 CM092 6 >100 6 >100 –11 >100
14 CM022G 1 48 4 48 –1 68
15 CM032D 3 17 6 49 0 65
16 CM2071F 4 >100 4 >100 –7 >100
17 CM3186B 2 65 9 72 7 >100
18 CM3141B 9 23 12 57 8 >100
19 BZA15 8 >100 17 >100 15 >100
20 AR02 –1 4 –3 20 –8 41
21 AR09 1 10 2 17 –9 45
22 BZA23 4 8 3 7 –5 76
23 CM3116A 0 18 –1 22 –9 20
24 CM3159A 4 27 5 26 –1 42
25 CM3146B –3 4 –4 11 –14 40
26 CM3129A 0 21 5 28 –30 3
27 MF1 2 15 0 41 –1 >100
28 MF27A –2 9 –2 25 –6 68
29 THN10 3 21 –1 32 –2 >100
30 THN6C 11 20 9 51 16 >100
31 CM3072B 3 10 3 3 2 76
32 CM3116C 5 1 3 3 –4 77
33 MF5 –1 44 –1 97 –7 >100
34 CM3159B –1 30 1 68 0 >100
35 AR27 0 –4 –4 –1 –14 69
36 MQ4 3 –23 –2 –18 –15 45
37 MQ8 7 –8 –9 –10 –11 18
38 BZA37 10 –6 9 10 2 75
39 CM4017A 0 3 –6 19 –11 38
40 CM3130B –6 23 –17 22 –26 29
41 CM4016A –1 6 –4 18 –11 58
42 CM3112B 0 40 –15 1 –26 12
43 SiA5 3 25 –14 25 –17 29
44 CM032E –2 19 –4 13 –12 20
45 MF4 –2 4 –2 41 –10 91
46 MF6 –2 1 –14 13 –13 92
aPresented results are expressed as percent values above (numbers) or under
(numbers with minus sign) the control value which is assumed as 100%. SD was
below 20% for each point, and it is not shown for clarity of presentation.
Compounds selected for further analyses are underlined.
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Applied Science) and TURBO DNA-freeTM Kit (Life Technologies)
according to the manufacturer’s guidelines. The amount and qual-
ity of RNA were evaluated by using NanoDrop spectrophotometer
(Eppendorf). In addition, the band patterns of total RNA was
visualized by agarose gel electrophoresis. Moreover, the absence
of DNA was verified by PCR amplification, and by quantitative
real-time reverse transcription-PCR (qRT-PCR).
cDNA synthesis via reverse transcription: Each cDNA was pre-
pared using Transcriptor Reverse Transcriptase and random hex-
amer primers (Roche Applied Science) following the protocols
supplied from the provider. 1.25 mg of the total RNA sample was
used as a template. The resulting cDNA mixture was diluted 10-
fold and analyzed in qRT-PCR.
Real-time PCR assay: qRT-PCR was performed with the
LightCycler 480 Real-Time PCR System (Roche Applied Science)
according to the procedure described previously14,37,38. Reactions
were prepared in Roche 96-well plates containing: 10ml 2 SYBR
Green I Master Mix (Roche Applied Science), 6.25 ml/ml cDNA, and
200 nM specific primers (Table 1). Real-time PCR amplification were
carried out for 55 cycles and cycling conditions were as follows:
an initial incubation at 95 C for 5min, followed by denaturation
at 95 C for 10 s, annealing at 60 C for 15 s, and extension at 72 C
for 5 s. No-template controls and a melting curve analysis were
performed for each reaction. The 16S rRNA gene was used as ref-
erence gene that showed no changes in expression levels in the
presence of H2O2 and tested compounds. Each experiment was
repeated three times.
Real-time PCR analysis: For precise relative quantification of
changes in the gene expression, the E-Method with efficiency cor-
rection was chosen. This method has been used and described in
detail by us previously37–39. The sample before addition of the
induction agent (3 h after inoculation) was a calibrator. The final
results were calculated using the following formula: Normalized
relative ratio¼ Et CT(t) calibratorCT(t) sample/Er CT(r) calibratorCT(r) sample,
where E is efficiency, t is target and r is reference. The raw run
data for E. coli strain MG1655 and U24B genes were transferred to
the LC480Conversion software and the efficiency and PCR effi-
ciency was calculated for each gene by LinRegPCR program.
Results
We have analyzed effects of 46 compounds (Supplementary
Figures S1–S4) on growth of E. coli MG1655 bacteria lysogenic
with phage U24B (a Shiga-toxin converting phage). Density of bac-
terial culture was measured at indicated time after prophage
induction with 0.2mg/ml mitomycin C in the presence and
absence of analyzed compounds. The results are presented in
Table 2.
Based on the analysis of growth inhibition of bacterial cultures,
15 compounds were selected to further studies. Most of them
were able to increase OD value of the mitomycin C-treated bacter-
ial culture, above 100% in at least one analyzed concentration.
The 15 compounds selected for further biological exploration
are presented in Figure 1. Indazole-4,7-dione IA011C was
Figure 1. Structures of the selected 15 compounds.
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synthesized in two steps from CM022G: reduction of the nitro
group by hydrogenation in acidic medium followed by oxidation
by PIFA40. Nitroindazoles CM022G40 and CM032D41 were pre-
pared by N-alkylation of the commercially available 7-nitro-1H-
indazole with respectively benzyl bromide or 4-(chloromethyl)-2-
methylthiazole as alkylating agent. Pyrazolo[4,5-g]quinoline-4,9-
dione CM2071F was obtained by a Diels-Alder reaction between
N,N-dimethylhydrazone and indazole-4,7-dione IA011C42.
Benzotriazole-4,7-dione CM092 was obtained by a 1,3-dipolar
cycloaddition of benzyl azide43 on commercial para-benzoquin-
one40. Carbazole-3,4-quinone BZ26 was obtained in two steps
from the commercially available 9-ethylcarbazol-3-amine. The for-
mation of the corresponding diazonium salt at 0 C followed by
Figure 2. Chemical procedure for the synthesis of targeted indenoindoles.
Figure 3. Correlations observed from NOE experiments for CM3072B.
Figure 4. Correlations observed from NOESY experiment for THN10.
Table 3. 2 D 1H–13 C HMBC correlations for AM10A (DMSO, 500.13MHz).
HMBC [J(C,H)]
Atom 13C 1H 1J 2J 3J 4J
1 145.1 2-H, 3-H 4-H
2 124.8 8.04 2-H
3 136.1 7.99 3-H
4 128.9 8.28 4-H
4a 148.8 4-H 3-H, 4b-OH 2-H
4b 94.6 4-H, 4b-OH, 1’-H, 3-H, 9b-OH
5a 164.9 7-H,1’-H 8-H
6 36.7 2.10 6-H 7-H 8-H
7 21.9 1.84 7-H 6-H, 8-H
8 24.2 2.41-2.77 8-H 7-H 6-H
9 188.7 7-H 6-H
9a 104.5 6-H, 8-H, 9b-OH
9b 83.3 9b-OH 4b-OH
10 192.8 9b-OH 2-H
10a 126.4 2-H, 4-H 3-H
1’ 44.9 4.61 1’-H CH3
Figure 5. NOESY interactions for AM10A.
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heating the latter in highly acidic aqueous solution gave 9-ethyl-
carbazol-3-ol, which was finally oxidized with Fremy’s salt44.
Oxazinocarbazole BZ70 was prepared by a Mannich type con-
densation of benzo[d]thiazol-2-ylmethanamine and formaldehyde
with 9-methylcarbazol-4-ol. This latter was obtained by a chemose-
lective N-alkylation of the commercially available carbazol-4-ol
which was achieved by generating the N,O-dianion with NaH in a
DMF/THF mixture under argon atmosphere at room temperature
and subsequent treatment with methyl iodide45. Dimethoxynin-
hydrins (2,2-dihydroxydimethoxyindane-2,3-diones) CM3186B and
CM3141B were prepared in a single step from the corresponding
commercial substituted indan-1-ones by microwave-assisted
Figure 6. Growth of E. coli MG1655 lysogenic with U24BDstx2::cat at 37 C in LB medium after induction with 0.5mg/ml mitomycin C (added to the culture at time
3 h) in the absence or presence of tested compounds at indicated concentrations (added to the culture at time 0). Bacterial growth was monitored by measurement of
A600 at indicated times. Presented results are mean values from three experiments with SD indicated as error bars.
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selenium oxidation46. Dihydroxyindeno[1,2-b]indole-9,10-dione
BZA1547 was prepared by condensation of ninhydrin and 3-(ben-
zylamino)cyclohex-2-en-1-one. 5-Isopropylindeno[1,2-b]indole-9,10-
dione derivatives MF148, THN10, THN6C49, MF5, and CM3159B,
were synthesized in two steps according to the method previously
described47: first, condensation between 3-(isopropylamino)cyclo-
hex-2-en-1-one 247 and the corresponding substituted ninhydrin,
then deoxygenation using tetraethylthionylamide (TETA)
(Figure 2).
Use of dimethoxyninhydrins CM3141B and CM3186B afforded
the dihydroxydimethoxyindeno[1,2-b]indole-9,10-diones CM3159A
and MF4, respectively, which were easily deoxygenated to give
the expected dimethoxyindenoindoles CM3159B and MF5.
Condensation of enaminone 2 with 4-methoxyninhydrin
CM3188B40 led to a mixture of the two regiosiomers 1- and 4-
methoxy (ratio 69/31) which could not be separated under clas-
sical conditions. After deoxygenation of the mixture, the two
regioisomers 1- and 4-methoxyindenoindoles were easily sepa-
rated by column chromatography and their assignment estab-
lished by NMR experiments. NOE experiment for the regioisomer
CM3072B (Figure 3) showed a correlation between the CH of the
isopropyl group and the methoxy group.
This correlation was not observed for the other regioisomer,
compound THN10. NOESY experiment for this latter showed
correlations (Figure 4) between the CH of the isopropyl group and
an aromatic proton (H-4), confirming unambiguously
the assignment.
Amino derivative MF1 was prepared from 4-nitroninhydrin
CM3020B40. The first coupling step led to the single 1-nitro
regioisomer AM10A. Assignment was established by NMR experi-
ments: 2 D NMR HSQC and 1H-13C HMBC correlations, using the
characteristic long-range 3J and 4J couplings and NOESY. All of the
cross couplings observed are reported in the Table 3, and the
decisive correlations for the structural assignment are summarized
in Figure 5.
The carbonyls C-9 and C-10 were firstly attributed due to the 3J
and 4J couplings between the protons 6-H and 7-H with C-9 on
the one hand, and OH-9 b and 2-H with C-10 on the other hand.
Then assignment of the C-4 b and C-9 b was allowed. In fact, only
the OH-9 b proton correlated with C-10 (3JH,C). Next, the cross cou-
plings found in the NOESY between the protons 4-H with OH-4 b
and the CH of isopropyl group allowed us to identify unambigu-
ously the proposed regiochemistry (Figure 5). This derivative
AM10A was then dedihydroxylated with TETA to afford AM12B.
Finally, the nitro group was reduced into amine MF1 using iron in
acidic conditions50.
Detailed analysis of effects of the tested 15 compounds on bac-
terial growth revealed various activities of different substances.
Figure 7. Relative phage titer in cultures of E. coli MG1655 lysogenic with U24BDstx2::cat treated with 0.5mg/ml mitomycin C (A) or 1mM H2O2 (B) (inducers were
added to the culture at time 3 h) in the absence (control experiments) or presence of tested compounds at indicted concentrations (added to the culture at time 0).
Presented results are mean values from three experiments with SD indicated as error bars.
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Figure 8. Viability of human HEK-293 and HDFa cells in cultures treated with tested compounds at indicated concentrations for 48 h. Cell viability was tested in the
MTT test. Presented results are mean values from three experiments with SD indicated as error bars. The significance of differences between control and cells treated
with tested compounds was assessed by the ANOVA test. Differences were marked by asterisks () and considered significant when the p value was <0.05.
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Induction of the lysogenic bacterial culture with mitomycin C
caused prophage induction and subsequent lysis of the host cells,
seen in Figure 6 as a decrease in the cell culture optical density.
However, majority of the selected compounds (BZ26, BZ70,
IA011C, CM092, CM032D, CM2071F, CM3141B, BZA15, MF1, THN10,
THN6C, MF5, CM3159B) ameliorated this effect, preventing bacter-
ial cell lysis after treatment with mitomycin C, in at least one used
concentration (Figure 6). These results suggested that such com-
pounds might prevent either effective prophage induction or
phage lytic development. Hence, we have measured titers of bac-
teriophages in cultures treated with mitomycin C with and
without the presence of tested compounds. In addition, hydrogen
peroxide was used as an inducing agent, as this substance was
found previously as a prophage inducer occurring naturally in
human gut. Contrary to mitomycin C, this inducer did not cause
detectable changes in the density of bacterial culture (data not
shown). In mitomycin C-treated lysogenic E. coli cell culture,
among the 15 selected compounds, the presence of most of them
in the culture caused a significant decrease in the titer of bacterio-
phage (Figure 7(A)). Importantly, in hydrogen peroxide-treated
cells, the effects of these compounds on phage titer were dra-
matic (Figure 7(B)).
These results indicate that in the presence of compounds
BZ26, BZ70, IA011C, CM092, CM022G, CM032D, CM2071F,
CM3186B, CM3141B, THN6C, U24B prophage induction and/or
phage lytic development is/are impaired. This suggest that at least
some of them might be considered as potential anti-STEC drugs.
Since any potential therapeutic must be safe for humans, we
have tested the selected 15 compounds for toxicity to human
cells. Model HEK-293 and HDFa cells were treated with these com-
pounds for 48 h in cultures, and their viability was assessed in the
MTT test (Figure 8).
Compounds BZ26, IA011C, CM092, and CM2071F were evi-
dently toxic to human cells which precludes their use as therapeu-
tics (Figure 8). Among the rest, there were substances neutral for
human cells’ viability or those even stimulating their growth (com-
pounds: BZ70, CM022G, CM032D, CM3186B, CM3141B, BZA15,
MF1, THN10, THN6C, MF5, and CM3159B) (Figure 8).
To learn about molecular mechanisms of impairment of pro-
phage induction and/or phage lytic development, expression of
selected phage and host genes was monitored quantitatively by
using qRT-PCR. Three compounds belonging to different groups of
human cell growth inhibitors (CM092), and neutral or weakly stim-
ulating agents (CM032D, CM3186B), were chosen for further
investigations (Figure 9).
In the absence of the prophage inducing agent, the influence
of compounds CM092, CM032D, and CM3186B on expression of
bacterial genes involved in the oxidative stress response, as well
as of bacteriophage genes crucial for either lytic (N, Q) or lyso-
genic (cI, cII) development was negligible (Figure 9(A)). However,
addition of hydrogen peroxide caused activation of the host
genes coding for the oxidative stress proteins, and phage genes
coding for antitermination proteins (as expected), while having
little effects on phage lysogenic proteins (also as expected)
Figure 9. Expression of bacterial genes coding for proteins involved in the oxidative stress response and of selected bacteriophage genes in E. coli MG1655 lysogenic
with U24BDstx2::cat either non-treated (A) or after induction with 1mM H2O2 (B) in the absence (control experiments) or presence of tested compounds added to final
concentration of 0.2mM. Levels of mRNAs were determined by RT-qPCR. Presented results are mean values from three experiments with SD indicated as error bars.
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(Figure 9(B)). Importantly, simultaneous presence of hydrogen
peroxide and any of the tested compounds caused a significant
decrease of the efficiency of expression of the oxidative stress
genes as well as phage genes (N, Q) supporting the lytic devel-
opment (Figure 9(B)). In contrast to these genes, expression of
the gene coding for the cI repressor was enhanced under these
conditions. These results suggest that compounds CM092,
CM032D, and CM3186B impair expression of bacterial genes
involved in the oxidative stress response, or ameliorate the
effects of oxidative stress. This leads to prevention of the pro-
phage induction by hydrogen peroxide.
Discussion and conclusions
Infections by STEC strains are particularly dangerous due to both
production of strong toxins (Shiga toxins) by these pathogens and
unavailability of the use of antibiotic therapy because these anti-
bacterial compounds may induce Stx prophage leading to
enhanced toxin synthesis and release2,3. Stx prophage induction is
required for effective expression of stx genes and production of
Shiga toxins2,17. Therefore, compounds which interfere with pro-
phage induction might be potential anti-STEC agents. Since it was
previously demonstrated that oxidative stress conditions are likely
responsible for Stx prophage induction in human intestine
infected with STEC (summarized in8), we asked whether com-
pounds revealing antioxidant features might be effective in inhib-
ition of Stx prophage induction, thus, diminishing pathogenicity of
STEC strains.
We have tested 46 compounds, derivatives of carbazole, inda-
zole, triazole, quinolone, ninhydrine, and indenoindole, and after
preliminary experiments, 15 of them were chosen for more
detailed analysis. These chemicals prevented or alleviated induc-
tion of Stx prophages by hydrogen peroxide, thus, revealing an
anti-STEC-pathogenicity potential. Importantly, out of 15 tested
compounds, eleven had acceptable profiles in the cytotoxicity MTT
test, i.e. they did not cause a decrease in viability of two human
cell lines (HEK-293 and HDFa). These might be considered for fur-
ther studies as potential anti-STEC drugs.
Studies on the mechanism of action of the selected com-
pounds, CM092, CM032D, and CM3186B, indicated that in E. coli
lysogenic with an Stx phage they had generally no significant
effects on expression of tested host and phage genes under
standard growth conditions. However, after addition of hydrogen
peroxide to the bacterial culture, all three tested compounds
caused drastic decrease in efficiency of expression of phage genes
involved in the lytic development and an increase in expression of
the cI gene, coding for the phage repressor, responsible for pro-
phage maintenance. These results demonstrate that CM092,
CM032D, and CM3186B prevent the prophage induction at the
level of expression of specific phage genes. This may arise from
interference with the oxidative stress, as in cells treated with
hydrogen peroxide, expression of genes involved in the oxidative
stress response was significantly less efficient in the presence of
the tested compounds. Therefore, the tested compounds appar-
ently reduce the oxidative stress in the presence of hydrogen per-
oxide, which prevents induction of Stx prophage in E. coli.
In conclusion, several compounds tested in this study, particu-
larly BZ70, CM022G, CM032D, CM3186B, CM3141B, BZA15,
MF1, THN10, THN6C, MF5, CM3159B, might be considered as
potential anti-STEC drugs, and qualified for further studies. At least
some of them, CM092, CM032D, and CM3186B, act by reduction
of the oxidative stress, changes in gene expression and prevention
of Stx prophage induction.
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